Open menu
Nanowerk

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

New JEOL Correlative Microscope Makes U.S. Debut

This August, JEOL USA will demonstrate the first correlative microscope to enable concurrent light microscopy and atmospheric scanning electron microscopy (ASEM) for observation of and experimentation on samples in their native state.

Posted: Jul 13th, 2010

Read more

P2i Acquires Surface Innovations

P2i, a world leader in liquid repellent nano-coating technology, has acquired 100 per cent of the share capital of Surface Innovations Ltd, a UK-based technology company with a wide range of functional nano-coating patents.

Posted: Jul 13th, 2010

Read more

Imec Welcomes New Research Partners To Its GaN Research Program

Micron Technology, Applied Materials, and Ultratech have joined the imec industrial affiliation program (IIAP) on GaN-on-Si technology. This multi-partner R+D program focuses on the development of GaN-on-Si (gallium nitride-on-silicon) process and equipment technologies for manufacturing solid state lighting (e.g. LEDs) and next-generation power electronics components on 8-inch Si wafers.

Posted: Jul 13th, 2010

Read more

SolRayo Utilizes NSF Grant to Develop New Nanomaterials for Commercial Use

SolRayo is developing new nanoparticle-based materials for commercial use in various renewable energy, industrial, consumer and automotive applications. The objective of the awarded grant is to address an issue concerning the degradation of performance of certain lithium batteries, particularly in high temperature applications.

Posted: Jul 13th, 2010

Read more

Midatech and Immunotope Form Joint Venture, Syntara LLC, for the Development of Immune Therapies

Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and Immunotope Inc, a biotechnology company focused on the development of immunotherapy products, today announced the formation of a joint venture Syntara LLC, to develop antigen based products for immune therapies to treat chronic viral infections and certain cancers.

Posted: Jul 13th, 2010

Read more